drugset / Trial / NCT00005024

Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease

NCT00005024 ↗

RandomizedSupportive care

Summary

RATIONALE: Antiemetic drugs such as granisetron may help to prevent nausea and vomiting in patients treated with chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of granisetron with that of a placebo in preventing nausea and vomiting after chemotherapy in patients who have malignant disease.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Granisetron Other / unclassified — Oral
Background Carboplatin Small molecule — Intravenous
Background Cyclophosphamide Other / unclassified — Intravenous
Background Doxorubicin Other / unclassified — Intravenous